Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy.

Liver international : official journal of the International Association for the Study of the Liver - 1 Jul 2013

Alfaleh Faleh Z, Alswat Khalid, Helmy Ahmed, Al-hamoudi Waleed, El-sharkawy Mohamed, Omar Mohanned, Shalaby Ahmed, Bedewi Mohaned A, Hadad Qais, Ali Safiyya M, Alfaleh Ahmad, Abdo Ayman A

Abstract excerpt

BACKGROUND & AIMS: Hepatitis C virus (HCV) genotype 4 (G4) infection is common in the Middle East. Post-treatment long-term outcomes have not been reported in these patients. This study evaluates these outcomes in patients after interferon-based therapy. PATIENTS AND METHODS: A total of 157 patients were followed from June 2001 to February 2012. Descriptive and analytical statistics, cumulative outcomes and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Interferons

Share to Kaplan-Meier Estimate

Share to Multivariate Analysis

Share to Ribavirin

Share to Viral Load

Source

Identifiers

PMID: 23490034
DOI: 10.1111/liv.12127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The natural history and long-term outcomes in patients with chronic hepatitis C genotype 4 after interferon-based therapy.PMID 23490034Read ↗

Hepatitis C genotype 4 therapy: increasing options and improving outcomes.Semantic proximity Read ↗

Hepatitis C genotype 4Semantic proximity Read ↗

Determinants of Infection Outcome in HCV-Genotype 4.Semantic proximity Read ↗

Factors influencing the response of interferon therapy in chronic hepatitis C patients.Semantic proximity Read ↗

Hepatitis C virus genotype 4 therapy: progress and challenges.Semantic proximity Read ↗

Sustained virological response in a predominantly hepatitis C virus genotype 4 infected population.Semantic proximity Read ↗

Hepatitis C Viral Kinetic Changes in a Retrospective Cohort Study of Chronic Hepatitis C Virus Egyptian Patients on Pegylated Interferon and Ribavirin Therapy.Semantic proximity Read ↗

Improving outcome in patients with hepatitis C virus genotype 4.Semantic proximity Read ↗

Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.Semantic proximity Read ↗

Outcomes and predictors of treatment response with sofosbuvir plus daclatasvir with or without ribavirin in Egyptian patients with genotype 4 hepatitis C virus infectionSemantic proximity Read ↗

Predictors of a sustained virological response in patients with genotype 4 chronic hepatitis C.Semantic proximity Read ↗

Response of different HCV genotypes to interferon therapy in different age groups of chronic hepatitis-C patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.